Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +25.00%
#4 Velvet Velvet +21.00%
#5 Fabric Protocol Fabric Protocol +18.10%
#6 Bedrock Bedrock +16.64%
#7 Nillion Nillion +14.65%
#8 Perle Perle +14.35%
#9 Nockchain Nockchain +14.08%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Rank in Stocks #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Share Price
$0.07
Last synced: 2024-11-12
Market Cap
$1.62M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Peak Bio, Inc. (PKBO)

Category

Healthcare
P/S ratio for Peak Bio, Inc. (PKBO)
P/S ratio as of 2026 TTM: 0
According to Peak Bio, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Peak Bio, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE